PicturaBio develops rapid pathogen detection systems that combine single-molecule fluorescence imaging with machine learning analysis. The platform acquires digital images of labeled biomolecules and classifies infectious agents in near real time. Proprietary hardware features a dedicated imager and single-use cartridges for point-of-care testing. Software pipelines analyze image data to deliver identification results and support diagnostic workflows. Offerings include instrumentation, consumables, and analytic software for imaging-based infectious disease testing. Funding awards, including support from DASA, back development of AI-driven assays and validation studies.